Patient-Reported Outcome Measures Used for Assessing Breast Sensation after Mastectomy: Not Fit for Purpose

Abstract

AIMS

The aims of this review were (i) to evaluate whether patient-reported outcome measures used in clinical studies for assessing sensation after mastectomy and breast reconstruction are suitable for this purpose, and (ii) to explore whether any measures used for assessing sensation after non-oncologic breast surgery are worth modifying for use in post-mastectomy patients.

Methods

PRISMA guidelines were followed (PROSPERO number CRD42020178066). We searched six databases for studies of oncologic (i.e., therapeutic, prophylactic, and reconstructive) and non-oncologic breast surgery (e.g., breast reduction) in which sensation was assessed with a patient-reported outcome measure. From the selected studies, we extracted eligible measures, evaluated their fitness for purpose, and summarized the content of sensation-specific items.

Results

Of 6728 articles identified, we selected 135 studies that used 124 eligible patient-reported outcome measures. For 97% of these measures, details regarding development and measurement properties were unavailable. Four (3%) validated measures—the Sensory Disturbances subscale of the Breast Cancer Sequelae Cause Scales, the Discomfort subscale of the Breast Sensation Assessment Scale (BSAS), Didier et al.’s questionnaire for “Assessment of the patients’ satisfaction with cosmetic results, physical and emotional impact of mastectomy”, and the Breast Specific Pain subscale of the Breast Cancer Treatment Outcomes Scale (BCTOS)—each contain at least one item pertaining to breast sensation, but target different concepts of interest. In total, the measures feature 215 sensation-specific items, most of which concern symptom severity (97%) as opposed to impact on daily functioning (3%).

Conclusion

Patient-reported outcome measures used in clinical studies for assessing sensation after mastectomy and breast reconstruction are unsuitable for this purpose: they are either non-validated or non-specific. We failed to identify any measures for use in non-oncologic breast surgery populations worth modifying. To collect meaningful, patient-relevant data regarding sensation after mastectomy, it is pertinent that future clinical trials adopt psychometrically robust, specific patient-reported outcome measures.

Supplementary Information

The online version contains supplementary material available at 10.1007/s40271-021-00565-5.

Key Points for Decision Makers

Patient questionnaires can inform us about added value of treatments aimed at preserving or restoring normal sensation after breast surgery.

This systematic review shows that patient questionnaires previously used for evaluating loss and regain of breast sensation are not fit for this purpose: their quality is unknown, or they evaluate outcomes broader than breast sensation alone.

To obtain valid results, future studies should adopt high-quality patient questionnaires that focus on breast sensation alone.

Introduction

After mastectomy and breast reconstruction for (pre-)malignant disease, patients are often confronted with loss of normal skin sensation [1, 2]. For many women, the breast and nipple are erogenous zones [3], and reduced sensation may negatively affect their sexual functioning. Tactile feedback could be an important mechanism by which patients recognize their reconstructed breast as part of their body, as is the case in hands [4]. In addition, reduced ability to sense heat predisposes reconstructed breasts to (severe) burns [5–8].

Growing recognition of the importance of breast sensation and adverse effects of loss of sensation have encouraged innovations to enhance sensory outcomes. Examples include skin- and nipple-sparing mastectomy, and ‘innervated’ breast reconstruction through surgical connection of sensory nerves or implantation of electronic sensors [9–11].

Loss or gain of injury-preventing sensation can be assessed through quantitative sensory testing [12]. But for evaluating whether attempts to preserve or restore sensation fulfill patient needs, asking them directly provides the only reasonable strategy. Patient-reported outcome measures1 do exactly this: they capture the patient’s perception of achieved results. They can focus on symptoms (e.g., pain, fatigue), functional outcomes (e.g., physical, sexual), or broader concepts such as health-related quality of life, and are increasingly included as trial endpoints to inform clinical practice and policy [13].

Three systematic reviews summarizing outcomes of innervated autologous breast reconstruction signaled a variety of patient-reported outcome measures used for assessing sensation [14–16], indicating absence of a standardized approach. The identified measures were not further described, let alone critically appraised. To guide future clinical trials toward selecting well-suited measures, we aimed (i) to evaluate whether patient-reported outcome measures used in clinical studies for assessing sensation after mastectomy and breast reconstruction are suitable for this purpose, and (ii) to consider whether sensation-specific measures used in studies of non-oncologic breast surgery populations are worth modifying for use in post-mastectomy patients.

Methods

Protocol and Registration

This systematic review was conducted in adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [17]. The review protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO), and is available at www.crd.york.ac.uk/PROSPERO, CRD42020178066.

Working Definition of Breast Sensation

To the best of our knowledge, there exists no agreed definition for the concept of breast sensation. We created and used a working definition comprising

• ability to feel sensory stimuli (e.g., touch, pressure, vibration, temperature, and pain) in the breast, the nipple, or both;

• ability to experience affective aspects of touch (e.g., pleasant, sexual) in the breast, the nipple, or both;

• ability of the nipple to become erect upon a sensory stimulus (e.g., cold, touch);

• symptoms indicating end-organ sensory loss (e.g., hypoesthesia, numbness, and anesthesia) in the breast, the nipple, or both.

The way the breast feels to the touch (e.g., texture, softness), and symptoms resulting from abnormal somatosensory processing (e.g., dysesthesia, paresthesia, hyperalgesia, allodynia, spontaneous pain, and phantom sensations) [18] fall outside this definition.

Search Strategy

In consultation with a librarian, we developed a search strategy [19] with controlled vocabulary and relevant keywords linked to three pillars: (i) breast or nipple surgery, (ii) sensation, and (iii) patient-reported outcome assessment (Online Resource 2, see ESM). Modifying and validating measures developed for a related population of interest can increase efficiency and opportunities for comparison [20]. Therefore, we searched for studies of oncologic (i.e., therapeutic, prophylactic, and reconstructive) as well as non-oncologic surgery (e.g., breast reduction). We searched six electronic databases (Medline [PubMed], Embase, CINAHL, Web of Science, Cochrane Library, and Google Scholar) for articles published before April 30, 2020. Database searches were supplemented by a manual backward reference check of systematic reviews summarizing sensory outcomes after various types of breast surgery. The United States National Library of Medicine clinical trials registry (ClinicalTrials.gov) was searched for studies in progress.

Study and Patient-Reported Outcome Measure Selection

We included peer-reviewed clinical studies of breast or nipple surgery if a patient-reported outcome measure was used to assess sensation. Conference abstracts, case reports, qualitative studies, and articles published in languages other than English, German, and French were excluded. After removing duplicates, H.P.S. and R.C.H.D. independently screened titles and abstracts of all studies, followed by retrieval and assessment of full-text articles. Studies unavailable in full text were excluded. Disagreements were resolved through discussion with M.L.K. From the selected studies, we identified all patient-reported outcome measures used for assessing breast sensation. Incompletely presented measures that could not be obtained from the corresponding author were excluded, as were measures without at least one item pertaining to breast sensation as defined in Sect. 2.2.

Data Extraction

The data extraction protocol was tested in five eligible articles and revised accordingly. H.P.S. extracted study- and measure-specific information (e.g., country of origin, study design, characteristics of study population, time elapsed from surgery to survey, concept of interest, sensation-specific items with response options, whether the concept of breast sensation makes up an independent score, information regarding development and measurement properties [Online Resource 3, see ESM]) into a Microsoft Excel spreadsheet. R.C.H.D. cross-checked data extracted from a random subset of 20 articles for accuracy and completeness.

Patient-Reported Outcome Measure Appraisal

We considered measures suitable for the purpose of assessing sensation after mastectomy and breast reconstruction, or worthy of adaptation for this purpose, (i) if they generate an independent score for the concept of breast sensation, and (ii) if they are valid and reliable according to the COnsensus-based Standards for the selection of health Measurement INstruments) methodology [21]. Measures that do not meet these criteria were considered unsuitable, as were measures for which information regarding development and measurement properties was unavailable. Quality and risk of bias of primary studies exceeded the scope of this review.

Item Content Synthesis

We compared sensation-specific items, looking for similarities regarding content and inductively grouping similar items into categories to form an affinity diagram [22]. Consensus on competing interpretations was achieved through discussion with M.L.K.

Results

Study and Patient-Reported Outcome Measure Selection

Our systematic search of the literature yielded 8563 citations, of which 6728 remained after deduplication. From 135 studies deemed relevant, we identified 124 eligible unique patient-reported outcome measures (Fig. 1).

Fig. 1.

PRISMA flow diagram of the study and patient-reported outcome measure selection process ^aReference lists of eight systematic reviews [2, 15, 16, 23–27] were scanned

Study Characteristics

Approximately half the included studies (51.1%) focused on oncologic breast surgery; the other half concerned non-oncologic procedures (Table 1 and Online Resource 4, see ESM). In 16.3% of studies, breast sensation was the primary endpoint. Few studies (12.6%) were prospective in design, whilst the vast majority (87.4%) used a cross-sectional design (i.e., patients completed the measure at just one postoperative follow-up moment). Additional quantitative sensory testing was performed in < 30% of studies.

Table 1.

Characteristics of included studies (n = 135)

	No. (%) of studies
Publication year
≤ 1994	13 (10)
1995–1999	14 (10)
2000–2004	20 (15)
2005–2009	21 (16)
2010–2014	36 (27)
2015–April 2020	31 (23)
Geographic origin
Europe	72 (53)
North America	39 (29)
Asia	15 (11)
Africa/South America/Australia	9 (7)
Study design
Cross-sectional study	118 (87)
Prospective cohort study	13 (10)
Randomized controlled trial	4 (3)
Breast surgery typea
Oncologic (therapeutic/prophylactic/reconstructive)	69 (51)
Breast-conserving surgery	10 (7)
Mastectomy	64 (47)
Skin-sparing mastectomy	43 (32)
Nipple-sparing mastectomy	16 (12)
Breast reconstruction	62 (46)
(Expander-)implant	41 (30)
Free flapb	38 (28)
Latissimus dorsi flap + implant	7 (5)
Nipple reconstructionc	15 (11)
Non-oncologic	66 (49)
Breast reduction/mastopexy	44 (33)
Breast augmentation	19 (14)
Lactiferous duct excision	2 (2)
Nipple reduction/inverted nipple correction	2 (2)
Breast sensation as study endpoint
Primary study endpoint	22 (16)
Secondary study endpoint	113 (84)
Sample size
10–49	46 (34)
50–99	29 (22)
100–149	24 (18)
≥ 150	36 (27)
Time elapsed from surgery to surveya
Preoperative	2 (2)
< 12 months	18 (13)
≥ 12 months	86 (64)
Unknown	29 (22)
Additional objective sensory testing
No	96 (71)
Yesa	39 (29)
Mechanical detection threshold	38 (28)
Thermal detection threshold (warmth/cold)	14 (10)
Pain threshold (pressure/heat)	10 (7)
Vibration detection threshold	5 (4)
Nipple erectility	5 (4)
Other	7 (5)

^aPercentages do not sum to 100 because more than one category could apply to a study

^bIncludes five studies of innervated free tissue flaps [28–32]

^cOnly studies that specifically evaluated outcomes of nipple reconstruction were counted

Patient-Reported Outcome Measure Characteristics

We identified four patient-reported outcome measures (3%) for which details regarding development and measurement properties were available: the Sensory Disturbances subscale of the Breast Cancer Sequelae Cause Scales [33], the Discomfort subscale of the Breast Sensation Assessment Scale (BSAS) [34], Didier et al.’s questionnaire for “Assessment of the patients’ satisfaction with cosmetic results, physical and emotional impact of mastectomy” [35], and the Breast Specific Pain subscale of the Breast Cancer Treatment Outcomes Scale (BCTOS) [36] (Fig. 2). These measures contain only one or three items related to breast sensation, and their summary scores represent different concepts of interest. The remaining 97% concerned ad hoc measures that were not validated, or only minimally (e.g., readability pilot test) [37–40]. Most ad hoc measures (92%) were used in a single study (Fig. 2). In six studies, items from existing patient-reported outcome measures were compiled into a new study-specific measure [39–44], whilst in the remaining studies, methods for item content generation were rarely described. Authors who used multi-item ad hoc measures often disaggregated sensation-specific item responses and analyzed them as a standalone score. The average number of sensation-specific items per measure was 1.7 (range 1–7).

Fig. 2.

Characteristics of included patient-reported outcome measures (n = 124). The left pie chart represents the proportion of validated (yellow segment) versus ad hoc patient-reported outcome measures (purple segment); the right pie chart shows the number of ad hoc measures that were reused in multiple studies. ^aSensory Disturbances subscale of the Breast Cancer Sequelae Cause Scales [33], Discomfort subscale of the Breast Sensation Assessment Scale (BSAS) [34], Didier et al.’s questionnaire for “Assessment of the patients’ satisfaction with cosmetic results, physical and emotional impact of mastectomy” [35], and Breast Specific Pain subscale of the Breast Cancer Treatment Outcomes Scale (BCTOS) [36]

Suitability of Measures

Since none of the identified validated measures generate an independent score for the concept of breast sensation, we considered them unsuitable for the purpose of assessing this outcome. The ad hoc measures were deemed unsuitable or unworthy of modification given the lack of available details regarding development and measurement properties.

Item Content

In total, the various measures contained 215 individual items related to breast sensation. Compilation of these items revealed similarities regarding the aspect of breast sensation evaluated (e.g., erogenous sensation), question type (i.e., symptom severity versus impact on daily functioning), and anatomical area (i.e., nipple versus the whole breast; Fig. 3 and Online Resource 4, see ESM). Most items investigated symptom severity (97%) and were framed in general terms (e.g., “To what extent is your sensation in the breast area reduced?” [45]) rather than in the context of everyday situations (e.g., “Do you experience any kind of sensibility in your reconstructed breast when […] taking a shower […]?” [1, 46]). Only 3% of items explored the perceived impact of breast sensation—or a lack thereof—on everyday (mostly sexual) functioning.

Fig. 3.

Affinity diagram showing categorized content of items related to breast sensation. The content of individual items pertaining to breast sensation (n = 215) was grouped on three different but equal levels: (1) the aspect of breast sensation evaluated (e.g., erogenous sensation); (2) question type: the patient’s rating of symptom severity (in absolute terms, in comparison to before the operation or to the unoperated side, or satisfaction with or importance of breast sensation) versus the perceived impact of present or absent breast sensation on everyday functioning; and (3) anatomical area (i.e., nipple versus the whole breast) [22]. Data are n (%). Categories within each column are mutually exclusive and percentages sum to 100. For an overview of individual items synthesized in this diagram, see Online Resource 4 in the ESM

Discussion

In this systematic review, we set out to describe patient-reported outcome measures used in clinical studies for assessing breast sensation. We found that (i) measures used in studies of mastectomy and breast reconstruction are unsuitable for this purpose, and (ii) measures used in studies of non-oncologic breast surgery are not worth modifying and validating for use in post-mastectomy patients. We identified two main categories of measures, inadequate for different reasons: (i) homegrown ad hoc measures of unknown validity and reliability, and (ii) validated measures that were intended to assess concepts of interest broader than—and sometimes unrelated to—breast sensation. What is lacking is a psychometrically robust, content-specific measure.

A crucial flaw of ad hoc measures is the lack of patient involvement during development and testing [47]. Measures based primarily on sources other than the target population cannot be assumed to address their priorities and concerns, and as such, they are unsuitable for informing us about the patient benefit of an intervention. Although few authors of included ad hoc measures stated the methods used to generate content, items themselves suggest a great deal about the degree of patient consultation. Examples include frequent use of medical vocabulary that patients may find difficult to understand (e.g., areola, erogenous, tactile), the quantitative nature of items (e.g., “percentage change from the preoperative situation” [48]), or their dubious relevance (e.g., “satisfaction with nipple sensation in job-related situations” [39]).

Unavailability of a patient-reported outcome measure suitable for the purpose of assessing breast sensation may have compelled authors to develop ad hoc measures specifically for their studies. Until the Breast-Q was introduced in 2009, this practice was common in the wider reconstructive and cosmetic breast surgery field [49]. Creating ad hoc measures is a pragmatic short-term fix, but leads to a proliferation of new, overlapping measures. This is unhelpful, both because the quality of data being collected is uncertain, and because the unmet need—a robust, specific measure—remains unaddressed.

To ensure that measures cover those aspects of concern to patients, their content should be informed by an open-ended understanding of what breast sensation means to them. Qualitative studies have previously touched upon patients’ perceptions regarding loss of normal sensation after lumpectomy [50], mastectomy alone [51], and post-mastectomy breast reconstruction [50–58], providing relevant insights, but failing to cover the concept in detail. Our own team interviewed healthy women to establish a holistic frame of reference for understanding breast sensation [59]. The themes covered in this framework go beyond physical sensations of numbness, touch, and temperature that are the primary focus of patient-reported outcome measures identified by this review (Fig. 3). This discrepancy between findings highlights the need for further qualitative work elucidating which aspects of sensation are relevant to patients operated on for (pre-)malignant breast disease.

We identified four validated measures: the Sensory Disturbances subscale of the Breast Cancer Sequelae Cause Scales [33], the Discomfort subscale of the Breast Sensation Assessment Scale (BSAS) [34], Didier et al.’s questionnaire for “Assessment of the patients’ satisfaction with cosmetic results, physical and emotional impact of mastectomy” [35], and the Breast Specific Pain subscale of the Breast Cancer Treatment Outcomes Scale (BCTOS) [36]. These are unsuitable for assessing breast sensation because their summary scores represent a different concept of interest. Other symptoms in the measure may blur subtle but potentially important changes in sensation caused by the intervention. In theory, sensation-specific items within these measures can be validated for independent scoring, though their narrow representation of the concept of breast sensation hardly justifies the effort.

Generic patient-reported outcome measures, which we excluded from this review altogether because they lack breast sensation-specific items, raise a similar problem. In the only completed randomized controlled trial to date regarding the effect of innervated autologous breast reconstruction on quality of life [60], Temple and colleagues used three validated measures that were “too general to detect changes related to breast sensation in a responsive and meaningful manner”, according to Alderman and Chung [61]. Stromps et al. studied spontaneous return of sensation after autologous breast reconstruction and used the generic SF-36 questionnaire to capture patient perspectives [62]. The authors refrained from drawing conclusions regarding patient-reported sensory outcomes because summary scores were likely influenced by factors beyond the intervention. To avoid this kind of problem, researchers are increasingly being encouraged to choose specific patient-reported outcomes (e.g., disease or intervention-specific symptoms), rather than broader concepts (e.g., health-related quality of life) as primary trial endpoints [13].

Large numbers of patients may benefit from a robust, sensation-specific measure. Breast cancer represents one in four cancer diagnoses among women globally [63]. In countries where breast reconstruction is relatively accessible—such as the Unites States, Australia, Japan, and several European countries—the non-weighted average uptake after therapeutic mastectomy is 17% [64]. Increasing numbers of women continue to live with the consequences of these surgeries owing to the rising incidence of breast cancer [65], a rapid increase in women with unilateral breast cancer electing bilateral mastectomy [66], and prolonged survival after diagnosis [67]. Special efforts are being made to preserve and restore these patients’ normal physical, sexual, and social functioning as much as possible. In this context, addressing loss of normal skin sensation is becoming an important reconstructive goal. The abundance of studies identified by this review indicates a widespread desire to evaluate patient benefit as a result of these efforts, and underlines the need for a high-quality measure.

At least two measures developed in adherence to established methodological standards have recently or will soon become available: (i) the Breast-Q Return of Sensation [68], and (ii) Abramsohn and colleagues’ PROMIS measure for breast function recovery after mastectomy in relation to women’s sexual functioning [69]. These measures have not yet been implemented in clinical research, and fell outside our eligibility criteria. However, with the advent of better-quality alternatives, there will soon be no reason to remain with ad hoc or ill-targeted measures in this field.

A limitation of our review is that the included measures did not allow for critical appraisal of their validity and reliability following the COSMIN methodology [21]. The ad hoc measures were characterized by an overall unavailability of details concerning development, impeding any assessment; the validated measures were off-topic and appraising their measurement properties would not have served the purpose of this review. Nonetheless, the available data allow us to conclude that studies have so far failed to assess patient-reported breast sensation in a methodologically rigorous way. This has not been highlighted before.

Conclusion

This systematic review demonstrates that patient-reported outcome measures used in clinical studies for assessing breast sensation are unfit to do the job. To gather sound data that can be compared within and across studies, it is paramount that rigorously developed measures be adopted. These measures should be specific enough to elucidate the real effects of an intervention and changes during a clinical trial. Additionally, they should reflect only those aspects that matter to patients, because in the case of breast sensation, the patient is always right.

Supplementary Information

Below is the link to the electronic supplementary material.

Declarations

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or non-profit sectors.

Conflicts of interest

None of the authors has a financial interest to declare in relation to the content of this article.

Ethics approval

Not applicable.

Consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data and material

All data analyzed during this review are included in this published article and its Online Resource files.

Code availability

N/A: no code or software was used.

Author’s contributions

Conceptualization: SMHT, MLK. Literature search and data extraction: HPS, RCHD. Data analysis: HPS, RCHD, MLK. Writing (original draft preparation): HPS, RCHD. Writing (review and editing): MLK, SMHT, and RRWJH. Supervision: MLK, SMHT, and RRWJH.